Expression of Metastasis-related nm23-Hl and nm23-H2 Genes in Ovarian Carcinomas: Correlation with Clinicopathology, EGFR, c-erbB-2, and c-erbB-3 Genes, and Sex Steroid Receptor Expression1

Cancer Research

Volumn 54, Issue 7, 1994, Pages 1825-1830

  Mandai, Masaki ^a   Konishi, Ikuo ^a   Koshiyama, Masafumi ^a   Mori, Takahide ^a   Arao, Shinji ^b   Tashiro, Hironori ^b   Okamura, Hitoshi ^b   Nomura, Hiroshi ^c   Hiai, Hiroshi ^c   Fukumoto2, Manabu ^c  

^a KYOTO UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c Chicago Ill   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; STEROID RECEPTOR;

ARTICLE; CELL ONCOGENE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METASTASIS; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN DETERMINATION; RNA ANALYSIS;

ADENOCARCINOMA; BASE SEQUENCE; DNA PRIMERS; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MOLECULAR SEQUENCE DATA; MONOMERIC GTP-BINDING PROTEINS; NEOPLASM METASTASIS; NEOPLASM STAGING; NUCLEOSIDE-DIPHOSPHATE KINASE; OLIGONUCLEOTIDE PROBES; OVARIAN NEOPLASMS; OVARY; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECEPTOR, ERBB-3; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 0028204496     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Fidler, I.J. Critical factors in the biology of human cancer metastasis: twenty-eighth G.M.A. Clowes Memorial Award Lecture. Cancer Res., 50: 6130-6138, 1990.
2. Liotta, L.A. Tumor invasion and metastasis-role of the extracellular matrix. Cancer Res., 46: 1-7, 1986.
3. Liotta, L., Steeg, P.S., and Stetler-Stevenson, W.G. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell, 64: 327-336, 1991.
4. Yu, D., Hamada, J., Zhang, H., Nicolson, G.L., and Hung, M.C. Mechanisms of c-erbB2/neu oncogene-induced metastasis and repression of metastatic properties by adenovirus 5 El A gene products. Oncogene, 7: 2263-2270, 1992.
5. Steeg, P.S., Bevilacqua, G., Kopper, L., Thorgeirsson, U.P., Talmadge, J.B., Liotta, L.A., and Sobel, M.E. Evidence for a novel gene associated with low tumor metastatic potential. J. Natl. Cancer Inst., 80: 200-204, 1988.
6. Leone, A., Seeger, R.C., Hong, C.M., Hu, Y.Y., Arboleda, M.J., Brodeur, G.M., Stram, D., Slamon, D.J., and Steeg, P.S. Evidence for nm23 RNA overexpression, DNA amplification and mutation in aggressive childhood neuroblastomas. Oncogene, 8: 855-865, 1993.
7. Rosengard, A., Krutzsch, H., Shearn, A., Biggs, J., Barker, E., Margulies, I., King, C., Liotta, L., and Steeg, P. Reduced nm23/Awd protein in tumor metastasis and aberrant Drosophila development. Nature (Lond.), 342: 177-180, 1989.
8. Hirayama, R., Sawai, S., Takagi, Y., Mishima, Y., Kimura, N., Shimada, N., Esaki, Y., Kurajima, C., and Hirokawa, K. Positive relationship between expression of anti-metastatic factor (nm23 gene product or nucleoside diphosphate kinase) and good prognosis in human breast cancer. J. Natl. Cancer Inst., 83: 1249-1250, 1991.
9. Barnes, R., Masood, S., Barker, E., Rosengard, A.M., Coggin, D.L., Crowell, T., King, C.R., Porter-Jordan, K., Wargotz, E., Liotta, L.A., and Steeg, P.S. Low nm23 protein expression in infiltrating ductal breast carcinomas correlates with reduced patient survival. Am. J. Pathol., 139: 245-250, 1991.
10. Hennessy, C., Henry, J.A., May, F.E.B., Westley, B.R., Angus, B., and Lennard, T.W.J. Expression of the antimetastatic gene nm23 in human breast cancer: an association with good prognosis. J. Natl. Cancer Inst., 83: 281-285, 1991.
11. Nakayama, T., Ohtsuru, A., Nakao, K., Shima, M., Nakata, K., Watanabe, K., Ishii, K., Kimura, N., and Nagataki, S. Expression in human hepatocellular carcinoma of nucleoside diphosphate kinase, a homologue of the nm23 gene product. J. Natl. Cancer Inst., 84: 1349-1354, 1992.
12. Florenes, V.A., Aamdal, S., Myklebost, O., Maelandsmo, G.M., Bruland, O.S., and Fodstad, O. Levels of nm23 messenger RNA in metastatic malignant melanomas: inverse correlation to disease progression. Cancer Res., 52: 6088-6091, 1992.
13. Nakayama, H., Yasui, W., Yokozaki, H., and Tahara, E. Reduced expression of nm23 is associated with metastasis of human gastric carcinomas. Jpn. J. Cancer Res., 84: 184-190, 1993.
14. Haut, M., Steeg, P.S., Willson, J.K.V., and Markowitz, S.D. Induction of nm23 gene expression in human colonic neoplasms and equal expression in colon tumors of high and low metastatic potential. J. Natl. Cancer Inst., 83: 712-716, 1991.
15. Hailat, N., Keim, D.R., Melhem, R.F., Zhu, X.X., Eckerskorn, C., Brodeur, G.M., Reynolds, C.P., Seeger, R.C., Lottspeich, F., Strahler, J.R., and Hanash, S.M. High levels of p. 9/nm23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplification. J. Clin. Invest., 88: 341-345, 1991.
16. Okamoto, A., Sameshima, Y., Yokoyama, S., Terashima, Y., Sugimura, T., Terada, M., and Yokota, J. Frequent allelic losses and mutations of the p. 3 gene in human ovarian cancer. Cancer Res., 57: 5171-5176, 1991.
17. Mazars, R., Pujol, P., Maudelone, T., Jeanteur, P., and Theillet, C. p. 3 mutations in ovarian cancer: a late event? Oncogene, 6: 1685-1690, 1991.
18. Feig, L.A., Bast, R.C., Knapp, R.C., and Cooper, G.M. Somatic activation of the rasK gene in a human ovarian carcinoma. Science (Washington DC), 223: 698-700, 1984.
19. Fukumoto, M., Estenson, R.D., Sha, L., Oakley, G.J., Twiggs, L.B., Adocock, L.L., Carson, L.F., and Roninson, I.B. Association of Ki-ras with amplified DNA sequences, detected in human ovarian carcinomas by a modified in-gel renaturation assay. Cancer Res., 49: 1693-1697, 1989.
20. Boltz, E.M., Kefford, R.F., Leary, J.A., Houghton, C.R., and Friedlander, M.L. Amplification of c-ras-Ki oncogene in human ovarian tumors. Int. J. Cancer, 43: 428-430, 1989.
21. Barker, V.V., Borst, M.P., Dixon, D., Hatch, K.D., Shingleton, H.M., and Miller, D. c-myc amplification in ovarian cancer. Gynecol. Oncol., 38: 340-342, 1990.
22. Tashiro, H., Miyazaki, K., Okamura, H., Iwai, A., and Fukumoto, M. c-myc overexpression in human primary ovarian tumors: its relevance to tumor progression. Int. J. Cancer, 50: 828-833, 1992.
23. Kacinski, B.M., Carter, D., Mittal, K., Yee, L.D., Scata, K.A., Donofrio, L., Chambers, S.K., Wang, K.I., Yang-Feng, T., Rohrschneider, L.R., and Rothwell, V.M. Ovarian adenocarcinomas express fms-complementary transcripts and fms antigen, often with coexpression of CSF-1. Am. J. Pathol., 137: 135-147, 1990.
24. Owens, O.J., Stewart, C., Brown, I., and Leak, R.E. Epidermal growth factor receptors (EGFR) in human ovarian cancer. Br. J. Cancer, 64: 907-910, 1991.
25. Yamamoto, T., Ikawa, S., Akiyama, T., Semba, K., Nomura, N., Miyajima, N., Saito, T., and Toyoshima, K. Similarity of protein encoded by the human c-erbB-2 gene to epidermal growth factor receptor. Nature (Lond.), 319: 230-234, 1986.
26. Slamon, D.J., Godolphin, W., Jones, L.A., Hoh, J.A., Wong, S.G., Keith, D.E., Levin, W.J., Stuart, S.G., Udove, J., Ullrich, A., and Press, M.F. Studies of HER-2/neu proto-oncogene in human breast and ovarian cancer. Science (Washington DC), 244: 707-712, 1989.
27. Zhang, X., Silvia, E., Gershenson, D., and Hung, M.C. Amplification and rearrangement of c-erbB proto-oncogenes in cancer of human female genital tract. Oncogene, 4: 985-989, 1989.
28. Berchuck, A., Kamel, A., Whitaker, R., Kerns, B., Olt, G., Kinney, R., Soper, J.T., Dodge, R., Clarke-Pearson, D.L., Marks, P., McKenzie, S., Yin, S., and Bast, R.C. Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer. Cancer Res., 50: 4087-4091, 1990.
29. Kraus, M., Issing, W., Miki, T., Popescu, N., and Aaronson, S. Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors. Proc. Natl. Acad. Sci. USA, 86: 9193-9197, 1989.
30. Plowman, G.D., Whitney, G.S., Neubauer, M.G., Green, J.M., McDonald, V.L., Todaro, G.J., and Shoyab, M. Molecular cloning and expression of an additional epidermal growth factor receptor-related gene. Proc. Natl. Acad. Sci. USA, 87: 4905-4909, 1990.
31. Stahl, J.A., Leone, A., Rosengard, A.M., Porter, L., King, C.R., and Steeg, P.S. Identification of a second human nm23 gene, nm23-H2. Cancer Res., 51: 445-449, 1991.
32. Gilles, A.M., Presecan, E., Vonica, A., and Lascu, I. Nucleoside diphosphate kinase from human erythrocytes. J. Biol. Chem., 266: 8784-8789, 1991.
33. Noonan, K.E., Beck, C., Holzmayer, T.A., Chin, J.E., Wunder, J.S., Andruis, I.L., Gazdar, A.F., Willman, C.L., Griffith, B., Von Hoff, D.D., and Roninson, I.B. Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc. Natl. Acad. Sci. USA, 87: 7160-7164, 1990.
34. Barber, H.R.K. New frontiers in ovarian cancer diagnosis and management. Yale J. Biol. Med., 64: 127-141, 1991.
35. FIGO. Changes in definitions of clinical staging for carcinoma of the cervix and ovary: International Federation of Gynecology and Obstetrics. Am. J. Obstet. Gynecol., 156: 263-264, 1987.
36. Chomczynski, P., and Sacchi, N. Single step method of RNA isolation by guanidinium-thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
37. Cleveland, D., Lopata, M., MacDonald, R., Cowan, N., Rutter, W., and Kirschner, M. Number and evolutionary conservation of α- and β-tubulin and cytoplasmic 0-and 7-actin genes using specific cloned cDNA probes. Cell, 20: 95-105, 1980.
38. Higashiyama, M., Doi, O., Yokouchi, H., Kodama, K., Nakamori, S., Tateishi, R., and Kimura, N. Immunohistochemical analysis of nm23 gene product/NDP kinase expression in pulmonary adenocarcinoma: lack of prognostic value. Br. J. Cancer, 66: 533-536, 1992.
39. Morrow, C.P., and Townsend, D.E. Tumors of the ovary: neoplasms derived from coelomic epithelium. In: C.P. Morrow and D.E. Townsend (eds.), Synopsis of Gynecologic Oncology, pp. 231-256. New York: John Wiley & Sons, 1987.
40. Kimura, N., and Shimada, N. Evidence for complex formation between GTP binding protein (Gs) and membrane-associated nucleoside diphosphate kinase. Biochem. Biophys. Res. Commun., 168: 99-106, 1990.
41. Wang, D., Konishi, I., Koshiyama, M., Nanbu, Y., Iwai, T., Nonogaki, H., Mori, T., and Fujii, S. Immunohistochemical localization of c-erbB-2 protein and epidermal growth factor receptor in normal surface epithelium, surface inclusion cysts, and common epithelial tumours of the ovary. Virchows Arch. A Pathol. Anat., 421: 393-400, 1992.
42. Bauknecht, T., Runge, M., Schwall, M., and Pfleiderer, A. Occurrence of epidermal growth factor receptors in human adnexal tumors and their prognostic value in advanced ovarian carcinomas. Gynecol. Oncol., 29: 147-157, 1988.
43. Berchuck, A., Rodriguez, G.C., Kamel, A., Dodge, R.K., Soper, J.T., Clarke-Pearson, D.L., and Bast, R.C. Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. Am. J. Obstet. Gynecol., 164: 669-674, 1991.
44. Prigent, S., Lemoine, N., Hughes, C., Plowman, G., Selden, C., and Gullick, W. Expression of the c-erbB-3 protein in normal human adult and fetal tissues. Oncogene, 7: 1273-1278, 1992.
45. Slamon, D. Expression of the nm23 gene and breast cancer prognosis. J. Natl. Cancer Inst., 83: 229-231, 1991.
46. Bevilacqua, G., Sobel, M.E., Liotta, L.A., and Steeg, P.S. Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential. Cancer Res., 49: 5185-5190, 1989.
47. Wang, L., Patel, U., Ghosh, L., Chen, H.C., and Banerjee, S. Mutation in the nm23 gene associated with metastasis in colorectal cancer. Cancer Res., 53: 717-720, 1993.
48. Ullrich, A., Coussens, L., and Hayflich, J.S. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature (Lond.), 309: 418-425, 1984.